Advertisement

In vivo imaging of axonal transport using MRI: aging and Alzheimer’s disease

  • Satoshi MinoshimaEmail author
  • Donna Cross
Article

Abstract

Purpose

MRI using manganese as a trans-synaptic axonal tracing agent can unveil dynamics of axonal transport in living subjects. We use this technology to test the hypotheses if impaired axonal transport is a significant pathophysiological process in aging and early Alzheimer’s disease (AD) and in part accounting for “selective vulnerability” of projection neurons in AD.

Methods

To allow quantitative assessment of axonal transport in vivo, we developed voxel-based statistical mapping technology as well as a tracer kinetic modeling method based on mass transport for manganese-enhanced MRI to estimate axonal transport rates in aging rats and AD transgenic mice.

Results

These techniques demonstrated manganese-enhanced signal changes in axonal projections of the olfactory tract and decreased axonal transport rates in rodent models of aging and AD.

Conclusion

Altered axonal transport may be a critical pathophysiological process in aging and AD. Manganese-enhanced MRI provides exciting opportunities for the investigations of altered axonal transport in AD and related disorders.

Keywords

Alzheimer’s disease MRI Axonal transport 

Notes

Conflict of interest statement

The authors declare that they have no relevant financial or any other interests in this manuscript.

References

  1. 1.
    Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer’s disease. Lancet 1994;344(8926):895.PubMedCrossRefGoogle Scholar
  2. 2.
    Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol 1997;42:85–94.PubMedCrossRefGoogle Scholar
  3. 3.
    Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306–19.PubMedCrossRefGoogle Scholar
  4. 4.
    Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, et al. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease. Neuroimage 2008;39:619–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Sokoloff L. Sites and mechanisms of function-related changes in energy metabolism in the nervous system. Dev Neurosci 1993;15:194–206.PubMedCrossRefGoogle Scholar
  6. 6.
    Minoshima S, Cross DJ, Foster NL, Henry TR, Kuhl DE. Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer’s disease. Pathophysiological implications. Ann NY Acad Sci 1999;893:350–2.PubMedCrossRefGoogle Scholar
  7. 7.
    Stokin GB, Goldstein LS. Axonal transport and Alzheimer’s disease. Annu Rev Biochem 2006;75:607–27.PubMedCrossRefGoogle Scholar
  8. 8.
    Kitt CA, Struble RG, Cork LC, Mobley WC, Walker LC, Joh TH, et al. Catecholaminergic neurites in senile plaques in prefrontal cortex of aged nonhuman primates. Neuroscience 1985;16:691–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Pautler RG, Koretsky AP. Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage 2002;16:441–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Pautler RG, Silva AC, Koretsky AP. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 1998;40:740–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Cross DJ, Minoshima S, Anzai Y, Flexman JA, Keogh BP, Kim Y, et al. Statistical mapping of functional olfactory connections of the rat brain in vivo. Neuroimage 2004;23:1326–35.PubMedCrossRefGoogle Scholar
  12. 12.
    Hyman BT, Arriagada PV, Van Hoesen GW. Pathologic changes in the olfactory system in aging and Alzheimer’s disease. Ann NY Acad Sci 1991;640:14–9.PubMedGoogle Scholar
  13. 13.
    Cross DJ, Flexman JA, Anzai Y, Morrow TJ, Maravilla KR, Minoshima S. In vivo imaging of functional disruption, recovery and alteration in rat olfactory circuitry after lesion. Neuroimage 2006;32:1265–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Ho DT, Schlosser P, Caplow T. Determination of longitudinal dispersion coefficient and net advection in the tidal Hudson river with a large-scale, high resolution SF6 tracer release experiment. Environ Sci Technol 2002;36:3234–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Cross DJ, Flexman JA, Anzai Y, Maravilla KR, Minoshima S. Age-related decrease in axonal transport measured by MR imaging in vivo. Neuroimage. 2007 (in press, Epub ahead of print).Google Scholar
  16. 16.
    Smith KD, Kallhoff V, Zheng H, Pautler RG. In vivo axonal transport rates decrease in a mouse model of Alzheimer’s disease. Neuroimage 2007;35:1401–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer’s disease. Science 2005;307:1282–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Departments of Radiology and BioengineeringUniversity of WashingtonSeattleUSA
  2. 2.Department of RadiologyUniversity of WashingtonSeattleUSA

Personalised recommendations